サマリー

世界のワクチン研究市場 2023-2027
ワクチン研究市場は2022-2027年に175.9億米ドル成長し、予測期間中のCAGRは9.88%で加速すると予測されています。この調査レポートは、ワクチン研究市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、全体的な市場環境に関する最新分析を提供しています。市場は、感染症の高い流行、慢性感染症に対する新規ワクチンのニーズ、アジュバントとワクチンデリバリーシステムが牽引しています。
Technavioのワクチン研究市場は以下のように区分されています：
エンドユーザー別
- 公的機関
- 民間
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間のワクチン研究市場の成長を促進する主な要因の1つとして、ワクチンの研究開発を加速するためのaiの採用を挙げている。また、高所得国や発展途上国におけるワクチン需要の変動や、新規ワクチンのR&Dの増加は、市場の大きな需要につながる。
本レポートでは、ワクチン研究市場について以下の分野をカバーしています：
- ワクチン研究市場のサイジング
- ワクチン研究市場予測
- ワクチン研究市場の産業分析
強固なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って、本レポートでは、アボットラボラトリーズ、アステラス製薬、アストラゼネカ、バイエルンノルディックAS、Bharat Biotech Ltd.、CanSino Biologics Inc.、CSL Ltd.、第一三共、Emergent BioSolutions Co.Ltd.、Emergent BioSolutions Inc.、GlaxoSmithKline Plc.、Johnson and Johnson Services Inc.、Merck and Co.Inc.、Moderna Inc.、Novavax Inc.、Panacea Biotec Ltd.、Pfizer Inc.、Sanofi、Serum Institute of India Pvt. Ltd.、武田薬品工業株式会社、Creative Biogene, Inc.Ltd.、武田薬品工業株式会社、Creative Biogene社。また、ワクチンリサーチ市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/vaccine-research-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Age Group
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global vaccine research market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global vaccine research market 2017 - 2021 ($ billion)
o 4.2 End-User Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - End-User Segment 2017 - 2021 ($ billion)
o 4.3 Age Group Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Age Group Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Public - Market size and forecast 2022-2027
o Exhibit 34: Chart on Public - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Public - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Public - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Public - Year-over-year growth 2022-2027 (%)
o 6.4 Private - Market size and forecast 2022-2027
o Exhibit 38: Chart on Private - Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Private - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Private - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Private - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by End-user
o Exhibit 42: Market opportunity by End-user ($ billion)
o Exhibit 43: Data Table on Market opportunity by End-user ($ billion)
• 7 Market Segmentation by Age Group
o 7.1 Market segments
o Exhibit 44: Chart on Age Group - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Age Group - Market share 2022-2027 (%)
o 7.2 Comparison by Age Group
o Exhibit 46: Chart on Comparison by Age Group
o Exhibit 47: Data Table on Comparison by Age Group
o 7.3 Pediatric - Market size and forecast 2022-2027
o Exhibit 48: Chart on Pediatric - Market size and forecast 2022-2027 ($ billion)
o Exhibit 49: Data Table on Pediatric - Market size and forecast 2022-2027 ($ billion)
o Exhibit 50: Chart on Pediatric - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Pediatric - Year-over-year growth 2022-2027 (%)
o 7.4 Adult - Market size and forecast 2022-2027
o Exhibit 52: Chart on Adult - Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Data Table on Adult - Market size and forecast 2022-2027 ($ billion)
o Exhibit 54: Chart on Adult - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Adult - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Age Group
o Exhibit 56: Market opportunity by Age Group ($ billion)
o Exhibit 57: Data Table on Market opportunity by Age Group ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 Canada - Market size and forecast 2022-2027
o Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 107: Abbott Laboratories - Overview
o Exhibit 108: Abbott Laboratories - Business segments
o Exhibit 109: Abbott Laboratories - Key news
o Exhibit 110: Abbott Laboratories - Key offerings
o Exhibit 111: Abbott Laboratories - Segment focus
o 12.4 Astellas Pharma Inc.
o Exhibit 112: Astellas Pharma Inc. - Overview
o Exhibit 113: Astellas Pharma Inc. - Product / Service
o Exhibit 114: Astellas Pharma Inc. - Key news
o Exhibit 115: Astellas Pharma Inc. - Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 116: AstraZeneca Plc - Overview
o Exhibit 117: AstraZeneca Plc - Product / Service
o Exhibit 118: AstraZeneca Plc - Key news
o Exhibit 119: AstraZeneca Plc - Key offerings
o 12.6 Bavarian Nordic AS
o Exhibit 120: Bavarian Nordic AS - Overview
o Exhibit 121: Bavarian Nordic AS - Product / Service
o Exhibit 122: Bavarian Nordic AS - Key offerings
o 12.7 Bharat Biotech Ltd.
o Exhibit 123: Bharat Biotech Ltd. - Overview
o Exhibit 124: Bharat Biotech Ltd. - Product / Service
o Exhibit 125: Bharat Biotech Ltd. - Key news
o Exhibit 126: Bharat Biotech Ltd. - Key offerings
o 12.8 CanSino Biologics Inc.
o Exhibit 127: CanSino Biologics Inc. - Overview
o Exhibit 128: CanSino Biologics Inc. - Product / Service
o Exhibit 129: CanSino Biologics Inc. - Key offerings
o 12.9 CSL Ltd.
o Exhibit 130: CSL Ltd. - Overview
o Exhibit 131: CSL Ltd. - Business segments
o Exhibit 132: CSL Ltd. - Key news
o Exhibit 133: CSL Ltd. - Key offerings
o Exhibit 134: CSL Ltd. - Segment focus
o 12.10 Daiichi Sankyo Co. Ltd.
o Exhibit 135: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 136: Daiichi Sankyo Co. Ltd. - Product / Service
o Exhibit 137: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 138: Daiichi Sankyo Co. Ltd. - Key offerings
o 12.11 Emergent BioSolutions Inc.
o Exhibit 139: Emergent BioSolutions Inc. - Overview
o Exhibit 140: Emergent BioSolutions Inc. - Product / Service
o Exhibit 141: Emergent BioSolutions Inc. - Key news
o Exhibit 142: Emergent BioSolutions Inc. - Key offerings
o 12.12 GlaxoSmithKline Plc
o Exhibit 143: GlaxoSmithKline Plc - Overview
o Exhibit 144: GlaxoSmithKline Plc - Business segments
o Exhibit 145: GlaxoSmithKline Plc - Key news
o Exhibit 146: GlaxoSmithKline Plc - Key offerings
o Exhibit 147: GlaxoSmithKline Plc - Segment focus
o 12.13 Johnson and Johnson Services Inc.
o Exhibit 148: Johnson and Johnson Services Inc. - Overview
o Exhibit 149: Johnson and Johnson Services Inc. - Business segments
o Exhibit 150: Johnson and Johnson Services Inc. - Key news
o Exhibit 151: Johnson and Johnson Services Inc. - Key offerings
o Exhibit 152: Johnson and Johnson Services Inc. - Segment focus
o 12.14 Merck and Co. Inc.
o Exhibit 153: Merck and Co. Inc. - Overview
o Exhibit 154: Merck and Co. Inc. - Business segments
o Exhibit 155: Merck and Co. Inc. - Key news
o Exhibit 156: Merck and Co. Inc. - Key offerings
o Exhibit 157: Merck and Co. Inc. - Segment focus
o 12.15 Novavax Inc.
o Exhibit 158: Novavax Inc. - Overview
o Exhibit 159: Novavax Inc. - Product / Service
o Exhibit 160: Novavax Inc. - Key offerings
o 12.16 Panacea Biotec Ltd.
o Exhibit 161: Panacea Biotec Ltd. - Overview
o Exhibit 162: Panacea Biotec Ltd. - Product / Service
o Exhibit 163: Panacea Biotec Ltd. - Key offerings
o 12.17 Pfizer Inc.
o Exhibit 164: Pfizer Inc. - Overview
o Exhibit 165: Pfizer Inc. - Product / Service
o Exhibit 166: Pfizer Inc. - Key news
o Exhibit 167: Pfizer Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Age Group
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global vaccine research market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - End-User Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Age Group Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on End-user - Market share 2022-2027 (%)
Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Public - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Public - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Public - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Public - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Private - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Private - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Private - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Private - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by End-user ($ billion)
Exhibits43: Data Table on Market opportunity by End-user ($ billion)
Exhibits44: Chart on Age Group - Market share 2022-2027 (%)
Exhibits45: Data Table on Age Group - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Age Group
Exhibits47: Data Table on Comparison by Age Group
Exhibits48: Chart on Pediatric - Market size and forecast 2022-2027 ($ billion)
Exhibits49: Data Table on Pediatric - Market size and forecast 2022-2027 ($ billion)
Exhibits50: Chart on Pediatric - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Pediatric - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Adult - Market size and forecast 2022-2027 ($ billion)
Exhibits53: Data Table on Adult - Market size and forecast 2022-2027 ($ billion)
Exhibits54: Chart on Adult - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Adult - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Age Group ($ billion)
Exhibits57: Data Table on Market opportunity by Age Group ($ billion)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ billion)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Abbott Laboratories - Overview
Exhibits108: Abbott Laboratories - Business segments
Exhibits109: Abbott Laboratories - Key news
Exhibits110: Abbott Laboratories - Key offerings
Exhibits111: Abbott Laboratories - Segment focus
Exhibits112: Astellas Pharma Inc. - Overview
Exhibits113: Astellas Pharma Inc. - Product / Service
Exhibits114: Astellas Pharma Inc. - Key news
Exhibits115: Astellas Pharma Inc. - Key offerings
Exhibits116: AstraZeneca Plc - Overview
Exhibits117: AstraZeneca Plc - Product / Service
Exhibits118: AstraZeneca Plc - Key news
Exhibits119: AstraZeneca Plc - Key offerings
Exhibits120: Bavarian Nordic AS - Overview
Exhibits121: Bavarian Nordic AS - Product / Service
Exhibits122: Bavarian Nordic AS - Key offerings
Exhibits123: Bharat Biotech Ltd. - Overview
Exhibits124: Bharat Biotech Ltd. - Product / Service
Exhibits125: Bharat Biotech Ltd. - Key news
Exhibits126: Bharat Biotech Ltd. - Key offerings
Exhibits127: CanSino Biologics Inc. - Overview
Exhibits128: CanSino Biologics Inc. - Product / Service
Exhibits129: CanSino Biologics Inc. - Key offerings
Exhibits130: CSL Ltd. - Overview
Exhibits131: CSL Ltd. - Business segments
Exhibits132: CSL Ltd. - Key news
Exhibits133: CSL Ltd. - Key offerings
Exhibits134: CSL Ltd. - Segment focus
Exhibits135: Daiichi Sankyo Co. Ltd. - Overview
Exhibits136: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits137: Daiichi Sankyo Co. Ltd. - Key news
Exhibits138: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits139: Emergent BioSolutions Inc. - Overview
Exhibits140: Emergent BioSolutions Inc. - Product / Service
Exhibits141: Emergent BioSolutions Inc. - Key news
Exhibits142: Emergent BioSolutions Inc. - Key offerings
Exhibits143: GlaxoSmithKline Plc - Overview
Exhibits144: GlaxoSmithKline Plc - Business segments
Exhibits145: GlaxoSmithKline Plc - Key news
Exhibits146: GlaxoSmithKline Plc - Key offerings
Exhibits147: GlaxoSmithKline Plc - Segment focus
Exhibits148: Johnson and Johnson Services Inc. - Overview
Exhibits149: Johnson and Johnson Services Inc. - Business segments
Exhibits150: Johnson and Johnson Services Inc. - Key news
Exhibits151: Johnson and Johnson Services Inc. - Key offerings
Exhibits152: Johnson and Johnson Services Inc. - Segment focus
Exhibits153: Merck and Co. Inc. - Overview
Exhibits154: Merck and Co. Inc. - Business segments
Exhibits155: Merck and Co. Inc. - Key news
Exhibits156: Merck and Co. Inc. - Key offerings
Exhibits157: Merck and Co. Inc. - Segment focus
Exhibits158: Novavax Inc. - Overview
Exhibits159: Novavax Inc. - Product / Service
Exhibits160: Novavax Inc. - Key offerings
Exhibits161: Panacea Biotec Ltd. - Overview
Exhibits162: Panacea Biotec Ltd. - Product / Service
Exhibits163: Panacea Biotec Ltd. - Key offerings
Exhibits164: Pfizer Inc. - Overview
Exhibits165: Pfizer Inc. - Product / Service
Exhibits166: Pfizer Inc. - Key news
Exhibits167: Pfizer Inc. - Key offerings
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations